Health

Scrapped Covid vaccine deal with Valneva cost UK taxpayers £358m


A spokesman for Valneva said the firm was “exploring options for its Almeida manufacturing facility in Livingston, initially built to produce its Covid-19 vaccine, including a possible sale or a repurposing to produce its vaccine for Japanese Encephalitis, and its chikungunya vaccine, if approved”.



READ SOURCE

Readers Also Like:  Children waiting over a year in pain for NHS tooth removal

This website uses cookies. By continuing to use this site, you accept our use of cookies.